Malvinder Mohan Singh
Rank: No 5
Company: Ranbaxy Laboratories Limited
Designation: Chief executive officer and managing director
Compensation: Rs 19.58 crore (Rs 195.8 million)
Ranbaxy market cap: Rs 8,536.22 crore (Rs 85.36 billion)
About: Malvinder, with his brother Shivender, are the 13th richest Indians according to Forbes. In the list of the world's richest billionaires they come in at no 462.
Last year, the brothers sold their 34 per cent stake in generics maker Ranbaxy Laboratories to Japan's Daiichi Sankyo for $2 billion. The Daiichi-Ranbaxy combine is now the 15th biggest pharmaceutical company in the world.
Malvinder remains chairman and chief executive of Ranbaxy and will earn a salary and allowances of Rs 25 crore (Rs 250 million) per annum as against Rs 19.58 crore (Rs 195.8 million) earlier.
Post-acquisition, the Singh family has approximately Rs 10,000 crore (Rs 100 billion). They continue to retain their interest in Fortis Healthcare and Religare Financial Services.
Image: Malvinder Mohan Singh | Photograph: Vijay Mathur/Reuters
Also read: Who will win the 'world's best job?'
| Live updates on money.rediff.com |
|